Additionally, analyses of cytokines, chemokines, and soluble receptors were conducted in MS patients and AQP4-IgG-positive NMO patients, but not in AQP4-IgG-negative NMO patients [36]. This evidence concerns the gene AQP4 and neuromyelitis optica.